These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders. Macavei I, Galatâr N. Morphol Embryol (Bucur); 1989 Sep; 35(2):117-27. PubMed ID: 2529429 [Abstract] [Full Text] [Related]
8. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases]. Nafe R, Holgado de Colombo S, Choritz H, Georgii A. Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012 [Abstract] [Full Text] [Related]
10. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy]. Matolcsy A, Kónya T, Wéber E. Orv Hetil; 1992 Jun 28; 133(26):1617-20, 1625-6. PubMed ID: 1614699 [Abstract] [Full Text] [Related]
11. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H. J Pathol; 2005 Apr 28; 205(5):548-57. PubMed ID: 15726648 [Abstract] [Full Text] [Related]
18. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Nafe R, Georgii A, Kaloutsi V, Fritsch RS, Choritz H. Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 May 19; 61(2):111-6. PubMed ID: 1683718 [Abstract] [Full Text] [Related]
19. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population. Rudzki Z, Papla B, Stachura J. Pol J Pathol; 2004 May 19; 55(1):13-23. PubMed ID: 15195702 [Abstract] [Full Text] [Related]
20. [Histopathology and molecular pathology of chronic myeloproliferative disorders]. Kreipe HH. Veroff Pathol; 1993 May 19; 141():1-158. PubMed ID: 8372486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]